Table 2.
Frequency of studies estimating prognostic value of tissue-miRNA expression in colorectal cancer
| miR | n | Reference(s) | miR | n | Reference(s) | miR | n | Reference(s) | miR | n | Reference(s) | miR | n | Reference(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| let7a-5p | 1 | 31 | 34a-5p | 1 | 99 | 143 | 6 | 59, 112, 150–153 | 211 | 1 | 197 | 487b | 1 | 233 |
| let7a-2 | 1 | 32 | 34a | 1 | 100 | 144 | 1 | 154 | 212 | 1 | 198 | 490-3p | 1 | 234 |
| let7a | 1 | 33 | 92a | 3 | 64, 101, 102 | 145 | 5 | 33, 64, 150, 155, 156 | 214 | 1 | 199 | 491-5p | 1 | 205 |
| let7b | 1 | 34 | 93 | 2 | 34, 103 | 148a* | 1 | 157 | 215 | 4 | 58, 155, 179, 200 | 494 | 2 | 34, 235 |
| let7c | 1 | 35 | 96-5p | 1 | 104 | 148a | 3 | 81, 158, 159 | 217 | 2 | 201, 202 | 498 | 1 | 215 |
| let7e | 1 | 18 | 96 | 1 | 105 | 149 | 2 | 160, 161 | 218 | 2 | 203, 204 | 503 | 3 | 227, 236, 237 |
| let7g* | 1 | 36 | 99a-3p | 1 | 36 | 150 | 1 | 162 | 221-3p | 1 | 205 | 505* | 1 | 36 |
| let7g | 1 | 37 | 99a | 2 | 35, 106 | 153 | 1 | 163 | 221* | 1 | 206 | 505 | 1 | 32 |
| let7i | 1 | 28 | 99b-5p | 1 | 107 | 154 | 1 | 164 | 221 | 2 | 28, 207 | 506 | 2 | 238, 239 |
| 7 | 3 | 34, 39, 40 | 100 | 2 | 106, 108 | 155 | 1 | 60 | 223 | 1 | 208 | 515-5p | 1 | 134 |
| 9 | 1 | 41 | 101 | 1 | 64 | 181a-1 | 1 | 32 | 224 | 5 | 206, 209–212 | 517a | 1 | 240 |
| 10b | 4 | 28, 42–44 | 103a | 1 | 58 | 181a | 5 | 18, 165–168 | 229-5p | 1 | 36 | 542-3p | 2 | 241, 242 |
| 15a-5p | 1 | 45 | 103-1 | 1 | 81 | 181b | 2 | 18, 169 | 296 | 1 | 213 | 556 | 1 | 67 |
| 15a | 1 | 46 | 103 | 1 | 109 | 181 c | 1 | 170 | 320a | 1 | 28 | 570 | 1 | 157 |
| 16 | 3 | 46–48 | 106a-5p | 1 | 110 | 182 | 3 | 171–173 | 320e | 1 | 214 | 573 | 1 | 134 |
| 17-5p | 3 | 49–51 | 106a | 7 | 49, 64, 67, 111–114 | 183 | 1 | 174 | 320 | 1 | 215 | 579 | 1 | 134 |
| 17 | 1 | 52 | 106b | 3 | 58, 115, 116 | 185 | 1 | 133 | 326 | 1 | 216 | 590-5p | 2 | 243, 244 |
| 18a | 2 | 53, 54 | 107 | 1 | 36 | 187 | 2 | 175, 176 | 328 | 1 | 32 | 592 | 2 | 186, 245 |
| 19b | 1 | 38 | 124-5 p | 1 | 9 | 188-3p | 1 | 177 | 335 | 1 | 217 | 610 | 1 | 246 |
| 20a-5p | 2 | 55, 56 | 124 | 2 | 117, 118 | 191 | 1 | 178 | 337-5p | 1 | 36 | 625-3p | 1 | 247 |
| 20a | 2 | 57, 58 | 125b | 5 | 33, 35, 106, 112, 119 | 192 | 2 | 179, 180 | 338-3p | 1 | 218 | 625 | 1 | 248 |
| 21 | 17 | 5, 58–73 | 126 | 6 | 120–125 | 193a-5p | 1 | 181 | 340 | 1 | 219 | 630 | 1 | 249 |
| 22 | 2 | 74, 75 | 128 | 2 | 126, 127 | 193b | 1 | 182 | 342-3p | 1 | 205 | 638 | 1 | 250 |
| 23b | 2 | 76, 77 | 130a | 1 | 81 | 194 | 3 | 38, 183, 184 | 361-5p | 1 | 220 | 652 | 1 | 32 |
| 24-3p | 2 | 78, 79 | 130b | 1 | 128 | 195-5p | 1 | 33 | 362-3p | 1 | 157 | 664-3p | 1 | 186 |
| 25 | 1 | 80 | 132 | 2 | 129, 130 | 195 | 2 | 33, 34 | 365-1 | 1 | 76 | 720 | 1 | 251 |
| 26a-2 | 1 | 81 | 133a | 2 | 131, 132 | 196a | 1 | 185 | 365-2 | 1 | 76 | 802 | 1 | 134 |
| 26b | 1 | 82 | 133b | 2 | 133, 134 | 196b-5p | 1 | 186 | 365 | 1 | 221 | 875-5p | 1 | 252 |
| 29a | 2 | 83, 84 | 134 | 1 | 135 | 196b | 1 | 185 | 370 | 1 | 36 | 885-5p | 1 | 28 |
| 29b | 1 | 85 | 135b | 3 | 136–138 | 197 | 1 | 32 | 372 | 1 | 222 | 889 | 1 | 36 |
| 30a-5p | 1 | 86 | 137 | 2 | 139, 140 | 198 | 1 | 187 | 376a | 1 | 223 | 944 | 1 | 157 |
| 30a | 1 | 87 | 138-5p | 2 | 141, 142 | 199a-3p | 1 | 188 | 378a-3p | 1 | 224 | 1260b | 1 | 253 |
| 30b | 1 | 88 | 138 | 1 | 143 | 199b | 1 | 189 | 378a-5p | 1 | 224 | 1288 | 1 | 254 |
| 30d | 1 | 89 | 139-3p | 1 | 144 | 200a | 3 | 82, 149, 190 | 378 | 1 | 225 | 1290 | 1 | 29 |
| 31-3p | 2 | 90, 91 | 139-5p | 2 | 18, 145 | 200c | 3 | 23, 149, 191 | 422a | 2 | 141, 226 | 1292 | 1 | 227 |
| 31-5p | 3 | 91–93 | 139 | 1 | 146 | 203 | 2 | 24, 192 | 424-3p | 1 | 227 | 1297 | 1 | 255 |
| 31 | 4 | 64, 94–96 | 140-5p | 2 | 147, 148 | 204-5p | 2 | 193, 194 | 429 | 5 | 149, 228–231 | 1826 | 1 | 256 |
| 32 | 2 | 32, 97 | 141 | 2 | 34, 149 | 206 | 1 | 195 | 450b-5p | 1 | 232 | 4500 | 1 | 257 |
| 33b | 1 | 98 | 143-5p | 1 | 58 | 210 | 1 | 196 | 455-5p | 1 | 186 | 4775 | 1 | 258 |
Note: Highlighted studies were included in the present meta-analysis.